Raia Drogasil (RADLY) versus Its Competitors Head-To-Head Survey

Raia Drogasil (OTCMKTS:RADLY) is one of 150 public companies in the “Consumer Staples Distribution & Retail” industry, but how does it contrast to its peers? We will compare Raia Drogasil to related businesses based on the strength of its profitability, analyst recommendations, risk, earnings, institutional ownership, dividends and valuation.

Dividends

Raia Drogasil pays an annual dividend of $0.04 per share and has a dividend yield of 1.0%. Raia Drogasil pays out 26.7% of its earnings in the form of a dividend. As a group, “Consumer Staples Distribution & Retail” companies pay a dividend yield of 3.8% and pay out 36.7% of their earnings in the form of a dividend.

Valuation and Earnings

This table compares Raia Drogasil and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Raia Drogasil	$7.92 billion	$232.27 million	27.53
Raia Drogasil Competitors	$34.28 billion	$835.88 million	16.32

Raia Drogasil’s peers have higher revenue and earnings than Raia Drogasil. Raia Drogasil is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a breakdown of current ratings and price targets for Raia Drogasil and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Raia Drogasil	0	1	1	0	2.50
Raia Drogasil Competitors	2241	8236	10014	453	2.41

Raia Drogasil presently has a consensus price target of $5.20, indicating a potential upside of 25.91%. As a group, “Consumer Staples Distribution & Retail” companies have a potential upside of 61.25%. Given Raia Drogasil’s peers higher possible upside, analysts clearly believe Raia Drogasil has less favorable growth aspects than its peers.

Institutional and Insider Ownership

45.0% of shares of all “Consumer Staples Distribution & Retail” companies are held by institutional investors. 19.7% of shares of all “Consumer Staples Distribution & Retail” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Raia Drogasil and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Raia Drogasil	2.99%	20.12%	5.88%
Raia Drogasil Competitors	-25.67%	1.91%	2.62%

About Raia Drogasil

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It also markets its goods through telesales and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.